List of Tables
Table 1. Global Topoisomerase I Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Topoisomerase I Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Topoisomerase I Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global Topoisomerase I Inhibitors Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Topoisomerase I Inhibitors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Topoisomerase I Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Topoisomerase I Inhibitors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Topoisomerase I Inhibitors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Topoisomerase I Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Topoisomerase I Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Topoisomerase I Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of Topoisomerase I Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Topoisomerase I Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Topoisomerase I Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Topoisomerase I Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Topoisomerase I Inhibitors Sales by Region (2020-2025) & (K Units)
Table 18. Global Topoisomerase I Inhibitors Sales Market Share by Region (2020-2025)
Table 19. Global Topoisomerase I Inhibitors Sales by Region (2026-2031) & (K Units)
Table 20. Global Topoisomerase I Inhibitors Sales Market Share by Region (2026-2031)
Table 21. Global Topoisomerase I Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Topoisomerase I Inhibitors Revenue Market Share by Region (2020-2025)
Table 23. Global Topoisomerase I Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Topoisomerase I Inhibitors Revenue Market Share by Region (2026-2031)
Table 25. North America Topoisomerase I Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Topoisomerase I Inhibitors Sales by Country (2020-2025) & (K Units)
Table 27. North America Topoisomerase I Inhibitors Sales by Country (2026-2031) & (K Units)
Table 28. North America Topoisomerase I Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Topoisomerase I Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Topoisomerase I Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Topoisomerase I Inhibitors Sales by Country (2020-2025) & (K Units)
Table 32. Europe Topoisomerase I Inhibitors Sales by Country (2026-2031) & (K Units)
Table 33. Europe Topoisomerase I Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Topoisomerase I Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Topoisomerase I Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Topoisomerase I Inhibitors Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Topoisomerase I Inhibitors Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Topoisomerase I Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Topoisomerase I Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Topoisomerase I Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Topoisomerase I Inhibitors Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Topoisomerase I Inhibitors Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Topoisomerase I Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Topoisomerase I Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Topoisomerase I Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Topoisomerase I Inhibitors Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Topoisomerase I Inhibitors Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Topoisomerase I Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Topoisomerase I Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Topoisomerase I Inhibitors Sales (K Units) by Type (2020-2025)
Table 51. Global Topoisomerase I Inhibitors Sales (K Units) by Type (2026-2031)
Table 52. Global Topoisomerase I Inhibitors Sales Market Share by Type (2020-2025)
Table 53. Global Topoisomerase I Inhibitors Sales Market Share by Type (2026-2031)
Table 54. Global Topoisomerase I Inhibitors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Topoisomerase I Inhibitors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Topoisomerase I Inhibitors Revenue Market Share by Type (2020-2025)
Table 57. Global Topoisomerase I Inhibitors Revenue Market Share by Type (2026-2031)
Table 58. Global Topoisomerase I Inhibitors Price (US$/Unit) by Type (2020-2025)
Table 59. Global Topoisomerase I Inhibitors Price (US$/Unit) by Type (2026-2031)
Table 60. Global Topoisomerase I Inhibitors Sales (K Units) by Application (2020-2025)
Table 61. Global Topoisomerase I Inhibitors Sales (K Units) by Application (2026-2031)
Table 62. Global Topoisomerase I Inhibitors Sales Market Share by Application (2020-2025)
Table 63. Global Topoisomerase I Inhibitors Sales Market Share by Application (2026-2031)
Table 64. Global Topoisomerase I Inhibitors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Topoisomerase I Inhibitors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Topoisomerase I Inhibitors Revenue Market Share by Application (2020-2025)
Table 67. Global Topoisomerase I Inhibitors Revenue Market Share by Application (2026-2031)
Table 68. Global Topoisomerase I Inhibitors Price (US$/Unit) by Application (2020-2025)
Table 69. Global Topoisomerase I Inhibitors Price (US$/Unit) by Application (2026-2031)
Table 70. Novartis AG Company Information
Table 71. Novartis AG Description and Business Overview
Table 72. Novartis AG Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novartis AG Topoisomerase I Inhibitors Product
Table 74. Novartis AG Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer Topoisomerase I Inhibitors Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Teva Pharmaceutical Industries Company Information
Table 81. Teva Pharmaceutical Industries Description and Business Overview
Table 82. Teva Pharmaceutical Industries Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Teva Pharmaceutical Industries Topoisomerase I Inhibitors Product
Table 84. Teva Pharmaceutical Industries Recent Developments/Updates
Table 85. MOH Holdings Company Information
Table 86. MOH Holdings Description and Business Overview
Table 87. MOH Holdings Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. MOH Holdings Topoisomerase I Inhibitors Product
Table 89. MOH Holdings Recent Developments/Updates
Table 90. Yakult Honsha Company Information
Table 91. Yakult Honsha Description and Business Overview
Table 92. Yakult Honsha Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Yakult Honsha Topoisomerase I Inhibitors Product
Table 94. Yakult Honsha Recent Developments/Updates
Table 95. Daiichi Sankyo Company Information
Table 96. Daiichi Sankyo Description and Business Overview
Table 97. Daiichi Sankyo Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Daiichi Sankyo Topoisomerase I Inhibitors Product
Table 99. Daiichi Sankyo Recent Developments/Updates
Table 100. Servier Laboratories (Aust) Company Information
Table 101. Servier Laboratories (Aust) Description and Business Overview
Table 102. Servier Laboratories (Aust) Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Servier Laboratories (Aust) Topoisomerase I Inhibitors Product
Table 104. Servier Laboratories (Aust) Recent Developments/Updates
Table 105. Nippon Kayaku Company Information
Table 106. Nippon Kayaku Description and Business Overview
Table 107. Nippon Kayaku Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Nippon Kayaku Topoisomerase I Inhibitors Product
Table 109. Nippon Kayaku Recent Developments/Updates
Table 110. Meitheal Pharmaceuticals Company Information
Table 111. Meitheal Pharmaceuticals Description and Business Overview
Table 112. Meitheal Pharmaceuticals Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Meitheal Pharmaceuticals Topoisomerase I Inhibitors Product
Table 114. Meitheal Pharmaceuticals Recent Developments/Updates
Table 115. Grand Pharmaceutical Company Information
Table 116. Grand Pharmaceutical Description and Business Overview
Table 117. Grand Pharmaceutical Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Grand Pharmaceutical Topoisomerase I Inhibitors Product
Table 119. Grand Pharmaceutical Recent Developments/Updates
Table 120. Summit Medical Company Information
Table 121. Summit Medical Description and Business Overview
Table 122. Summit Medical Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Summit Medical Topoisomerase I Inhibitors Product
Table 124. Summit Medical Recent Developments/Updates
Table 125. Chong Kun Dang Pharmaceutical Company Information
Table 126. Chong Kun Dang Pharmaceutical Description and Business Overview
Table 127. Chong Kun Dang Pharmaceutical Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Chong Kun Dang Pharmaceutical Topoisomerase I Inhibitors Product
Table 129. Chong Kun Dang Pharmaceutical Recent Developments/Updates
Table 130. Ipsen SA Company Information
Table 131. Ipsen SA Description and Business Overview
Table 132. Ipsen SA Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Ipsen SA Topoisomerase I Inhibitors Product
Table 134. Ipsen SA Recent Developments/Updates
Table 135. Les Laboratoires Servier SAS Company Information
Table 136. Les Laboratoires Servier SAS Description and Business Overview
Table 137. Les Laboratoires Servier SAS Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Les Laboratoires Servier SAS Topoisomerase I Inhibitors Product
Table 139. Les Laboratoires Servier SAS Recent Developments/Updates
Table 140. Eton Pharmaceuticals Company Information
Table 141. Eton Pharmaceuticals Description and Business Overview
Table 142. Eton Pharmaceuticals Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Eton Pharmaceuticals Topoisomerase I Inhibitors Product
Table 144. Eton Pharmaceuticals Recent Developments/Updates
Table 145. CSPC Pharmaceutical Company Information
Table 146. CSPC Pharmaceutical Description and Business Overview
Table 147. CSPC Pharmaceutical Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. CSPC Pharmaceutical Topoisomerase I Inhibitors Product
Table 149. CSPC Pharmaceutical Recent Developments/Updates
Table 150. Hengrui Pharmaceuticals Company Information
Table 151. Hengrui Pharmaceuticals Description and Business Overview
Table 152. Hengrui Pharmaceuticals Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Hengrui Pharmaceuticals Topoisomerase I Inhibitors Product
Table 154. Hengrui Pharmaceuticals Recent Developments/Updates
Table 155. Kelun Pharmaceutical Company Information
Table 156. Kelun Pharmaceutical Description and Business Overview
Table 157. Kelun Pharmaceutical Topoisomerase I Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Kelun Pharmaceutical Topoisomerase I Inhibitors Product
Table 159. Kelun Pharmaceutical Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Topoisomerase I Inhibitors Distributors List
Table 163. Topoisomerase I Inhibitors Customers List
Table 164. Topoisomerase I Inhibitors Market Trends
Table 165. Topoisomerase I Inhibitors Market Drivers
Table 166. Topoisomerase I Inhibitors Market Challenges
Table 167. Topoisomerase I Inhibitors Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Topoisomerase I Inhibitors
Figure 2. Global Topoisomerase I Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Topoisomerase I Inhibitors Market Share by Type: 2024 & 2031
Figure 4. Camptothecin Derivatives Product Picture
Figure 5. Non-camptothecin Product Picture
Figure 6. Global Topoisomerase I Inhibitors Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Topoisomerase I Inhibitors Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Topoisomerase I Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Topoisomerase I Inhibitors Market Size (2020-2031) & (US$ Million)
Figure 13. Global Topoisomerase I Inhibitors Sales (2020-2031) & (K Units)
Figure 14. Global Topoisomerase I Inhibitors Average Price (US$/Unit) & (2020-2031)
Figure 15. Topoisomerase I Inhibitors Report Years Considered
Figure 16. Topoisomerase I Inhibitors Sales Share by Manufacturers in 2024
Figure 17. Global Topoisomerase I Inhibitors Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Topoisomerase I Inhibitors Players: Market Share by Revenue in Topoisomerase I Inhibitors in 2024
Figure 19. Topoisomerase I Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Topoisomerase I Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Topoisomerase I Inhibitors Sales Market Share by Country (2020-2031)
Figure 22. North America Topoisomerase I Inhibitors Revenue Market Share by Country (2020-2031)
Figure 23. United States Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Topoisomerase I Inhibitors Sales Market Share by Country (2020-2031)
Figure 26. Europe Topoisomerase I Inhibitors Revenue Market Share by Country (2020-2031)
Figure 27. Germany Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Topoisomerase I Inhibitors Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Topoisomerase I Inhibitors Revenue Market Share by Region (2020-2031)
Figure 34. China Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Topoisomerase I Inhibitors Sales Market Share by Country (2020-2031)
Figure 42. Latin America Topoisomerase I Inhibitors Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Topoisomerase I Inhibitors Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Topoisomerase I Inhibitors Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Topoisomerase I Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Topoisomerase I Inhibitors by Type (2020-2031)
Figure 53. Global Revenue Market Share of Topoisomerase I Inhibitors by Type (2020-2031)
Figure 54. Global Topoisomerase I Inhibitors Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Topoisomerase I Inhibitors by Application (2020-2031)
Figure 56. Global Revenue Market Share of Topoisomerase I Inhibitors by Application (2020-2031)
Figure 57. Global Topoisomerase I Inhibitors Price (US$/Unit) by Application (2020-2031)
Figure 58. Topoisomerase I Inhibitors Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
